Model cell lines for the study of apoptosis in vitro

Methods in Cell Biology

Volumn , Issue 66, 2001, Pages 417-436

  Valavanis, Christos ^a   Hu, Yanhui ^a   Yang, Yili ^b   Osborne, Barbara A ^a   Chouaib, Salem ^c   Greene, Lloyd ^d   Ashwell, Jonathan D ^b   Schwartz, Lawrence M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; CELL CULTURE; CELL LINE; CELL STRAIN; HUMAN; LEUKEMIA CELL LINE; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; APOPTOSIS; CELL LINE; HUMANS; JURKAT CELLS; PC12 CELLS; RATS; TUMOR CELLS, CULTURED;

EID: 33845669249     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(01)66019-9     Document Type: Article

References (101)

1. Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H., and Honjo, T. (1996). Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765-772.
2. Akamatsu, W., Okano, H. J., Osumi, N., Inoue, T., Nakamura, S., Sakakibara, S., Miura, M., Matsuo, N., Darnell, R. B., and Okano, H. (1999). Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc. Natl. Acad. Sci. USA 96, 9885-9890.
3. Ashwell, J. D., Cunningham, R. E., Noguchi, P. D., and Hernandez, D. (1987). Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165, 173-194.
4. Bacus, S. S., Kiguchi, K., Chin, D., King, C. R., and Huberman, E. (1990). Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol. Carcinogen. 3, 350-362.
5. Bertin, J., Armstrong, R. C., Ottilie, S., Martin, D. A., Wang, Y., Banks, S., Wang, G. H., Senkevich, T. G., Alnemri, E. S., Moss, B., Lenardo, M. J., Tomaselli, K. J., and Cohen, J. I. (1997). Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172-1176.
6. Biocca, S., Cattaneo, A., and Calissano, P. (1983). A macromolecular structure favouring microtubule assembly in NGF-differentiated pheochromocytoma cells (PC 12). EMBO J. 2, 643-648.
7. Blau, H. M., Pavlath, G. K., Hardeman, E. C., Chiu, C. P., Silberstein, L., Webster, S. G., Miller, S. C., and Webster, C. (1985). Plasticity of the differentiated state. Science 230, 758-766.
8. Boesen-de Cock, J. G., Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. (1999). Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation. J. Biol. Chem. 274, 14255-14261.
9. Boonen, G. J., van Oirschot, B. A., van Diepen, A., Mackus, W. J., Verdonck, L. F., Rijksen, G., and Medema, R. H. (1999). Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. J. Biol. Chem. 274, 34676-34682.
10. + T lymphoblastoid Jurkat cells. Eur. J. Immunol. 27, 2805-2811.
11. Bursch, W., Hochegger, K., Torok, L., Marian, B., Ellinger, A., and Hermann, R. S. (2000). Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci. 113, 1189-1198.
12. Butscher, W. G., Powers, C., Olive, M., Vinson, C., and Gardner, K. (1998). Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J. Biol. Chem. 273, 552-560.
13. Castellon, R., and Mirkin, B. L. (2000). Retroviral transfer of the beta-nerve growth factor gene into murine neuroectodermal tumor cells modulates cell proliferation rate, neurite formation, and NGF binding site expression. J. Neurosci. Res. 59, 265-275.
14. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T. H. (1996). The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation: Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271, 31929-31936.
15. Clarke, R., Skaar, T., Baumann, K., Leonessa, F., James, M., Lippman, J., Thompson, E. W., Freter, C., and Brunner, N. (1994). Hormonal carcinogenesis in breast cancer: Cellular and molecular studies of malignant progression. Breast Cancer Res. Treat. 31, 237-248.
16. Constantinou, A. I., Kamath, N., and Murley, J. S. (1998). Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer 34, 1927-1934.
17. da Silva, C. P., de Oliveira, C. R., da Conceicao, M., and de Lima, P. (1996). Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem. Pharmacol. 51, 1331-1340.
18. Demirhan, I., Hasselmayer, O., Chandra, A., Ehemann, M., and Chandra, P. (1998). Histone-mediated transfer and expression of the HIV-1 tat gene in Jurkat cells. J. Hum. Virol. 1, 430-440.
19. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., and Krammer, P. H. (1995). Autocrine T-cell suicide mediated by APO-1. Nature 373, 438-441.
20. Dominov, J. A., Dunn, J. J., and Miller, J. B. (1998). Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J. Cell Biol. 142, 537-544.
21. Fan, L., Owen, J. S., and Dickson, G. (1999). Construction and characterization of polycistronic retrovirus vectors for sustained and high-level co-expression of apolipoprotein A-I and lecithin-cholesterol acyltransferase. Atherosclerosis 147, 139-145.
22. Ferlini, C., Scambia, G., Marone, M., Distefano, M., Gaggini, C., Ferrandina, G., Fattorossi, A., Isola, G., Benedetti Panici, P., and Mancuso, S. (1999). Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br. J. Cancer 79, 257-263.
23. Geier, A., Beery, R., Haimsohn, M., and Karasik, A. (1995). Insulin-like growth factor-1 inhibits cell death induced by anticancer drugs in the MCF-7 cells: Involvement of growth factors in drug resistance. Cancer Invest. 13, 480-486.
24. Gibson, L. F., Fortney, J., Magro, G., Ericson, S. G., Lynch, J. P., and Landreth, K. S. (1999). Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy. Breast Cancer Res. Treat. 55, 107-117.
25. Gillis, S., and Watson, J. (1980). Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152, 1709-1719.
26. Greene, L. A., Farenelli, S. E., Cunningham, M. E., and Park, D. S. (1998). Culture and experimental use of the PC12 rat pheochromocytoma cell line. In "Culturing Nerve Cells" (G. Banker and K. Goslin, eds.), 2nd Ed., pp. 161-187. MIT Press, Cambridge, MA.
27. Greene, L. A., and Tischler, A. S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
28. Guchelaar, H. J., Vermes, I., Koopmans, R. P., Reutelingsperger, C. P., and Haanen, C. (1998). Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: A quantitative pharmacodynamic model. Cancer Chemother. Pharmacol. 42, 77-83.
29. Hartfield, P. J., Mayne, G. C., and Murray, A.W. (1997). Ceramide induces apoptosis in PC12 cells. FEBS Lett. 401, 148-152.
30. Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J., and Marrack, P. (1983). The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157, 1149-1169.
31. Hedrick, S. M., Matis, L. A., Hecht, T. T., Samelson, L. E., Longo, D. L., Heber-Katz, E., and Schwartz, R. H. (1982). The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell 30, 141-152.
32. Hirota, J., Furuichi, T., and Mikoshiba, K. (1999). Inositol 1,4,5-trisphosphate receptor type 1 is a substrate for caspase-3 and is cleaved during apoptosis in a caspase-3-dependent manner. J. Biol. Chem. 274, 34433-34437.
33. Hu, Y., Cascone, P. J., Cheng, L., Sun, D., Nambu, J. R., and Schwartz, L. M. (1999). Lepidopteran DALP, and its mammalian ortholog HIC-5, function as negative regulators of muscle differentiation. Proc. Natl. Acad. Sci. USA 96, 10218-10223.
34. Ivins, K. J., Ivins, J. K., Sharp, J. P., and Cotman, C. W. (1999). Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by beta-amyloid. J. Biol. Chem. 274, 2107-2112.
35. Jain, P. T., and Gewirtz, D. A. (1998). Estradiol enhances gene delivery to human breast tumor cells. J. Mol. Med. 76, 709-714.
36. Jänicke, R. U., Sprengart, M. L., Wati, M. R., and Porter, A. G. (1998). Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360.
37. Johnson, V. L., Cooper, I. R., Jenkins, J. R., and Chow, S. C. (1999). Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells. Exp. Cell Res. 251, 175-184.
38. Karas, M., Zaks, T. Z., Liu, J. L., and LeRoith, D. (1999). T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle. Mol. Biol. Cell 10, 4441-4450.
39. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766.
40. Katayose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K. H., and Seth, P. (1995). Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1(8), 889-897.
41. Kelner, G. S., Jenkins, M. K., and Jemmerson, R. (1993). A single amino acid substitution in a cytochrome c T cell stimulatory peptide changes the MHC restriction element from one isotype (I-Ak) to another (I-Ek). Mol. Immunol. 30, 569-575.
42. Kern, F. G., McLeskey, S. W., Zhang, L., Kurebayashi, J., Liu, Y., Ding, I. Y., Kharbanda, S., Chen, D., Miller, D., Cullen, K., and (1994). Transfected MCF-7 cells as a model for breast-cancer progression. Breast Cancer Res. Treat. 31, 153-165.
43. Lafyatis, R., Lechleider, R., Roberts, A. B., and Sporn, M. B. (1991). Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis. Mol. Cell. Biol. 11, 3795-3803.
44. Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F. X., Green, D. R., and Karin, M. (1999). Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19, 751-763.
45. Li, Y. Q., Hii, C. S., Der, C. J., and Ferrante, A. (1999). Direct evidence that ERK regulates the production/secretion of interleukin-2 in PHA/PMA-stimulated T lymphocytes. Immunology 96, 524-528.
46. Lindenboim, L., Haviv, R., and Stein, R. (1998). Bcl-xL inhibits different apoptotic pathways in rat PC12 cells. Neurosci. Lett. 253, 37-40.
47. Manna, S. K., Sah, N. K., and Aggarwal, B. B. (2000). Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis. J. Biol. Chem. 275, 13297-13306.
48. Manni, A., Wechter, R., Grove, R., Wei, L., Martel, J., and Demers, L. (1995). Polyamine profiles and growth properties of ornithine decarboxylase overexpressing MCF-7 breast cancer cells in culture. Breast Cancer Res. Treat. 34, 45-53.
49. Maroney, A. C., Finn, J. P., Bozyczko-Coyne, D., O'Kane, T. M., Neff, N. T., Tolkovsky, A. M., Park, D. S., Yan, C. Y., Troy, C. M., and Greene, L. A. (1999). CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J. Neurochem. 73(5), 1901-1912.
50. McGahon, A. J., Martin, S. J., Bissonnette, R. P., Mahboubi, A., Shi, Y., Mogil, R. J., Nishioka, W. K., and Green, D. R. (1995). The end of the (cell) line: Methods for the study of apoptosis in vitro. Methods Cell Biol. 46, 153-185.
51. McIlroy, D., Sakahira, H., Talanian, R. V., and Nagata, S. (1999). Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene 18, 4401-4408.
52. Memon, S. A., Petrak, D., Moreno, M. B., and Zacharchuk, C. M. (1995). A simple assay for examining the effect of transiently expressed genes on programmed cell death. J. Immunol. Methods 180, 15-24.
53. Mercep, M., Bluestone, J. A., Noguchi, P. D., and Ashwell, J. D. (1988). Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J. Immunol. 140, 324-335.
54. 2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142, 4085-4092.
55. Mielke, K., Damm, A., Yang, D. D., and Herdegen, T. (2000). Selective expression of JNK isoforms and stress-specific JNK activity in different neural cell lines. Brain Res. Mol. Brain Res. 75(1), 128-137.
56. Millecamps, S., Kiefer, H., Navarro, V., Geoffroy, M. C., Robert, J. J., Finiels, F., Mallet, J., and Barkats, M. (1999). Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression. Nat. Biotechnol. 17, 865-869.
57. Mills, J. C., Wang, S., Erecinska, M., and Pittman, R. N. (1995). Use of cultured neurons and neuronal cell lines to study morphological, biochemical, and molecular changes occurring in cell death. Methods Cell Biol. 46, 217-242.
58. Muller, S. R., Sullivan, P. D., Clegg, D. O., and Feinstein, S. C. (1990). Efficient transfection and expression of heterologous genes in PC12 cells. DNA Cell Biol. 9, 221-229.
59. Northrop, J. P., Crabtree, G. R., and Mattila, P. S. (1992). Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp. Med. 175, 1235-1245.
60. Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. (1993). Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12, 3679-3684.
61. Park, D. S., Morris, E. J., Stefanis, L., Troy, C. M., Shelanski, M. L., Geller, H. M., and Greene, L. A. (1998). Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J. Neurosci. 18, 830-840.
62. Pimentel-Muinos, F. X., and Seed, B. (1999). Regulated commitment of TNF receptor signaling: A molecular switch for death or activation. Immunity 11, 783-793.
63. Porn-Ares, M. I., Samali, A., and Orrenius, S. (1998). Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 5, 1028-1033.
64. Pratt, J. C., van den Brink, M. R., Igras, V. E., Walk, S. F., Ravichandran, K. S., and Burakoff, S. J. (1999). Requirement for Shc in TCR-mediated activation of a T cell hybridoma. J. Immunol. 163(5), 2586-2591.
65. Pratt, S. E., and Pollak, M. N. (1993). Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res. 53, 5193-5198.
66. Roosnek, E. E., Brouwer, M. C., and Aarden, L. A. (1985). T cell triggering by lectins. I. Requirements for interleukin 2 production; lectin concentration determines the accessory cell dependency. Eur. J. Immunol. 15, 652-656.
67. Rufini, S., Rainaldi, G., Abbracchio, M. P., Fiorentini, C., Capri, M., Franceschi, C., and Malorni, W. (1997). Actin cytoskeleton as a target for 2-chloro adenosine: Evidence for induction of apoptosis in C2C12 myoblastic cells. Biochem. Biophys. Res. Commun. 238, 361-366.
68. Ruiz-Ruiz, M. C., and Lopez-Rivas, A. (1999). p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells. Cell Death Differ. 6, 271-280.
69. Samali, A., Cai, J., Zhivotovsky, B., Jones, D. P., and Orrenius, S. (1999). Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 18, 2040-2048.
70. Sarin, A., Nakajima, H., and Henkart, P. A. (1995). A protease-dependent TCR-induced death pathway in mature lymphocytes. J. Immunol. 154, 5806-5812.
71. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H. G., and (1994). Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91, 9238-9242.
72. Schwartz, L. M., and Osborne, B. A. (1995). Cell death. Methods Cell Biol. 46, xv-xviii.
73. Schwartz, M., Sivron, T., Eitan, S., Hirschberg, D. L., Lotan, M., and Elman-Faber, A. (1994). Cytokines and cytokine-related substances regulating glial cell response to injury of the central nervous system. Prog. Brain Res. 103, 331-341.
74. Seth, P., Katayose, D., Li, Z., Kim, M., Wersto, R., Craig, C., Shanmugam, N., Ohri, E., Mudahar, B., Rakkar, A. N., Kodali, P., and Cowan, K. (1997). A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: A gene therapy approach for drug-resistant cancers. Cancer Gene Ther. 4, 383-390.
75. Shafer, T. J., and Atchison, W. D. (1991). Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: A model for neurotoxicological studies. Neurotoxicology 12, 473-492.
76. Shinoura, N., Satou, R., Yoshida, Y., Asai, A., Kirino, T., and Hamada, H. (2000). Adenovirus-mediated transfer of Bcl-X(L) protects neuronal cells from Bax-induced apoptosis. Exp. Cell Res. 254, 221-231.
77. Soule, H. D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409-1416.
78. Spinozzi, F., Pagliacci, M. C., Migliorati, G., Moraca, R., Grignani, F., Riccardi, C., and Nicoletti, I. (1994). The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk. Res. 18, 431-439.
79. Sreerama, L., and Sladek, N. E. (1995). Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide. Drug Metab. Dispos. 23, 1080-1084.
80. Stewart, C. E., and Rotwein, P. (1996). Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271, 11330-11338.
81. Stridh, H., Kimland, M., Jones, D. P., Orrenius, S., and Hampton, M. B. (1998). Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltin-induced apoptosis. FEBS Lett. 429, 351-355.
82. Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., Jr., and Shepard, H. M. (1985). Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945.
83. Teng, K. K., Angelastro, J. M., Cunningham, M. E., Farinelli, S. E., and Greene, L. A. (1998). Cultured PC12 cells: A model for neuronal function, differentiation and survival. In "Cell Biology: A Laboratory Handbook" (J. E. Celis, ed.), pp. 244-250. Academic Press, Orlando, FL.
84. Tetsuka, T., Uranishi, H., Imai, H., Ono, T., Sonta, S., Takahashi, N., Asamitsu, K., and Okamoto, T. (2000). Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats. J. Biol. Chem. 275, 4383-4390.
85. Tischler, A. S., and Greene, L. A. (1978). Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Lab. Invest. 39, 77-89.
86. Tognarini, M., and Villa-Moruzzi, E. (1998). Protein phosphatase I isoforms in differentiating C2C12 myocytes. Eur. J. Cell Biol. 76, 212-219.
87. Vashishtha, S. C., Nazarali, A. J., and Dimmock, J. R. (1998). Application of fluorescence microscopy to measure apoptosis in Jurkat T cells after treatment with a new investigational anticancer agent (N. C.1213). Cell Mol. Neurobiol. 18, 437-445.
88. Verhoven, B., Krahling, S., Schlegel, R. A., and Williamson, P. (1999). Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ. 6, 262-270.
89. 2+ 1. J. Immunol. 150, 5338-5349.
90. Wang, H. G., Takayama, S., Rapp, U. R., and Reed, J. C. (1996). Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 93, 7063-7068.
91. Wechsler-Reya, R. J., Elliott, K. J., and Prendergast, G. C. (1998). A role for the putative tumor suppressor Bin1 in muscle cell differentiation. Mol. Cell. Biol. 18, 566-575.
92. Weiss, A., Wiskocil, R. L., and Stobo, J. D. (1984). The role of T3 surface molecules in the activation of human T cells: A two-stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. J. Immunol. 133, 123-128.
93. Welsh, J. (1994). Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell. Biol. 72, 537-545.
94. White, J., Haskins, K. M., Marrack, P., and Kappler, J. (1983). Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies. J. Immunol. 130, 1033-1037.
95. Wiskocil, R., Weiss, A., Imboden, J., Kamin-Lewis, R., and Stobo, J. (1985). Activation of a human T cell line: A two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes. J. Immunol. 134, 1599-1603.
96. Xie, S. P., Pirianov, G., and Colston, K. W. (1999). Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. Eur. J. Cancer 35, 1717-1723.
97. Yaffe, D., and Saxel, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.
98. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. (1995). Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291.
99. Yang, Y., Mercep, M., Ware, C. F., and Ashwell, J. D. (1995). Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181, 1673-1682.
100. Zacharchuk, C. M., Mercep, M., Chakraborti, P., Simons, S. S., Jr., and Ashwell, J. D. (1990). Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145, 4037-4045.
101. Zhang, G. J., Kimijima, I., Onda, M., Kanno, M., Sato, H., Watanabe, T., Tsuchiya, A., Abe, R., and Takenoshita, S. (1999). Tamoxifen-induced apoptosis in breast cancer cells relates to downregulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. Clin. Cancer Res. 5, 2971-2977.